Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133982) titled 'Efficacy, safety, quality of life in treating Seropositive non-Sjogren's Syndrome Aqueous Deficiency Dry Eye with first-line topical cyclosporin 0.1%: a multicenter randomized controlled trial' on Oct. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Department of Ophthalmology and Visual Sciences (DOVS), Chinese University of Hong Kong
Condition:
Seropositive non-Sjogren's syndrome aqueous-deficient dry eye
Intervention:
Group 1:topical preservative-free lubricants 4 times a day
Group 2:unpreserved, single-dose 0.05% CsA CE eyedrops 4 times a day
Recruitment Status: Not Recruit...